Clinical Trials Browser

Interventional × Pancreatic Neoplasms × Ketamine × Clear all

NCT05086250 2026-05-08

Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Anxiety Disorders, Pancreatic Neoplasms

NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

Phase 2 Completed

Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

NCT02442739 2018-11-06

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Phase EARLY_PHASE1 Withdrawn

GastrointestinalHead & Neck

Depression, Head and Neck Neoplasms, Pancreatic Neoplasms